About SUNY / Health Sciences Ctr at Stony Brook
Clinical Trials at SUNY / Health Sciences Ctr at Stony Brook
During the past decade, SUNY / Health Sciences Ctr at Stony Brook conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SUNY / Health Sciences Ctr at Stony Brook" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials, followed by "Hoechst Marion Roussel" with 2 trials
sponsored, "Pharmacia and Upjohn" with 2 trials sponsored, "Sandoz" with 2 trials sponsored and "Abbott"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SUNY / Health Sciences Ctr at Stony Brook"
#1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator and "Glaxo Wellcome" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at SUNY / Health Sciences Ctr at Stony Brook
According to Clinical.Site data, the most researched conditions in "SUNY / Health Sciences Ctr at Stony Brook" are
"HIV Infections" (18 trials), "Diarrhea" (2 trials), "Candidiasis, Oral" (1 trials), "Chickenpox" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "SUNY / Health Sciences Ctr at Stony Brook" in a lesser frequency.
Clinical Trials Intervention Types at SUNY / Health Sciences Ctr at Stony Brook
Most popular intervention types in "SUNY / Health Sciences Ctr at Stony Brook" are "Drug" (18 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (6 trials), "Didanosine" (3 trials), "Celgosivir hydrochloride" (2 trials), "Delavirdine mesylate" (2 trials) and "Octreotide" (2 trials). Other intervention names were less common.
Clinical Trials Genders at SUNY / Health Sciences Ctr at Stony Brook
The vast majority of trials in "SUNY / Health Sciences Ctr at Stony Brook" are
18 trials for "All" genders.
Clinical Trials Status at SUNY / Health Sciences Ctr at Stony Brook
Currently, there are NaN active trials in "SUNY / Health Sciences Ctr at Stony Brook".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in SUNY / Health Sciences Ctr at Stony Brook,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SUNY / Health Sciences Ctr at Stony Brook, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 7 trials that are defined as “Not Applicable".